Delivery Order SPE2DR25D3005-SPE2DR26FP7LC
Award Date 11/24/25
Potential Completion Date 12/16/25
Potential Value $8.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Xeomin 200 Unit Vials, with a ceiling value of $23,553.20 and an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $98,923.44 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials. This competitively awarded, firm fixed-price contract is scheduled for completion by November 19, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of the company's pharmaceutical supply services to the federal government under its existing contract vehicle...
- The Defense Logistics Agency awarded a $23,553.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials. The contract, issued on November 17, 2025, has an ultimate completion date of December 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Xeomin 100 unit vials valued at $7,360.25. This firm fixed-price delivery order is scheduled for completion by December 17, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award utilized competitive procurement procedures without any set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Xeomin 50 unit vials valued at $10,941.84. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with a completion date of September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Xeomin 200 unit vials valued at $46,934.16, with completion scheduled for October 6, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $11,531.52 to AmerisourceBergen Drug Corp for the supply of Xeomin 50 Unit Vials, with a firm fixed price structure and an ultimate completion date of December 4, 2025. The award, announced on November 12, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle authorized...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,766.46 for 100-unit vials of Xeomin on December 3, 2025, with completion scheduled for December 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $35,329.80 to AmerisourceBergen Drug Corp for Xeomin 200 Unit Vials, with an ultimate completion date of December 24, 2025. This competitive award, issued on December 3, 2025, utilizes a firm fixed-price contract type with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,057.32 by the Defense Logistics Agency on June 2, 2025, for the supply of Xeomin 100 unit vials, with completion scheduled for June 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...